Qiagen NV
NYSE:QGEN

Watchlist Manager
Qiagen NV Logo
Qiagen NV
NYSE:QGEN
Watchlist
Price: 42.32 USD Market Closed
Market Cap: 9.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

QGEN Price Targets Summary
Qiagen NV

Wall Street analysts forecast QGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QGEN is 50.15 USD with a low forecast of 43.43 USD and a high forecast of 57.75 USD.

QGEN Lowest Forecast
Wall Street Target
43.43 USD
3% Upside
QGEN Average Forecast
Wall Street Target
50.15 USD
18% Upside
QGEN Highest Forecast
Wall Street Target
57.75 USD
36% Upside
Lowest
Price Target
43.43 USD
3% Upside
Average
Price Target
50.15 USD
18% Upside
Highest
Price Target
57.75 USD
36% Upside
Qiagen NV Competitors:
Price Targets
1548
Genscript Biotech Corp
90% Upside
4880
CellSource Co Ltd
41% Upside
ABSI
Absci Corp
250% Upside
BANB
Bachem Holding AG
45% Upside
1548
Genscript Biotech Corp
90% Upside
4880
CellSource Co Ltd
41% Upside
ABSI
Absci Corp
250% Upside
BANB
Bachem Holding AG
45% Upside
O
OABI
OmniAb Inc
467% Upside
603259
WuXi AppTec Co Ltd
40% Upside
SKAN
SKAN Group AG
28% Upside
ERF
Eurofins Scientific SE
5% Upside

Revenue
Forecast

Revenue Estimate
Qiagen NV

For the last 8 years the compound annual growth rate for Qiagen NV's revenue is 5%. The projected CAGR for the next 3 years is 6%.

5%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Qiagen NV

For the last 8 years the compound annual growth rate for Qiagen NV's operating income is 15%. The projected CAGR for the next 3 years is 13%.

15%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Qiagen NV

For the last 8 years the compound annual growth rate for Qiagen NV's net income is 0%. The projected CAGR for the next 3 years is 95%.

0%
Past Growth
95%
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

See Also

Summary
QGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
QGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QGEN stock valuation using valuation multiples.
Wall Street Estimates
QGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QGEN's stock price target?
Price Target
50.15 USD

According to Wall Street analysts, the average 1-year price target for QGEN is 50.15 USD with a low forecast of 43.43 USD and a high forecast of 57.75 USD.

What is Qiagen NV's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Qiagen NV's revenue is 5%. The projected CAGR for the next 3 years is 6%.

What is Qiagen NV's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Qiagen NV's operating income is 15%. The projected CAGR for the next 3 years is 13%.

What is Qiagen NV's Net Income forecast?
Projected CAGR
95%

For the last 8 years the compound annual growth rate for Qiagen NV's net income is 0%. The projected CAGR for the next 3 years is 95%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.